Cognitive Screening Among Older Adults with Diabetes Across Diverse Clinic Settings

Published:November 24, 2022DOI:



      Diabetes increases risk of cognitive dysfunction and dementia, which can make it harder to manage diabetes. We aimed to examine cognitive screening for older adults with diabetes in 1) endocrine (Endo), 2) geriatric (Geri) and 3) multidisciplinary endocrine-geriatric (Geri-Endo), to study differences between these settings and to elucidate risk factors of cognitive dysfunction.


      We performed cognitive screening for subsets of patients ≥ age 65 with diabetes in one large healthcare system. We compared results and differences from the three clinic types and used adjusted multivariate logistic regression models to predict risk of cognitive dysfunction.


      Among 198 patients screened, those in Geri-Endo (N=86) and Geri (N=32) were more likely to have lower Mini-Cog scores, higher prevalence of hypertension and cardiovascular (CV) events. Endo and Geri-Endo patients had longer durations of diabetes, higher incidence of hypoglycemia, and were more likely to use insulin. Age >75 years (p=0.0105), previous CV events (p=0.0006) and body mass index <30 (p=0.0115) were significantly associated with lower Mini-Cog scores.


      Our study shows that cognitive screening can help identify at risk older adults with diabetes. Thus, yearly screening should be part of routine diabetes care.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cdc
        Centers for Disease Control and Prevention.
        National Diabetes Statistics Report website. 2022;
        • Munshi M.N.
        Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know.
        Diabetes Care. 2017; 40: 461-467
        • Cukierman T.
        • Gerstein H.C.
        • Williamson J.D.
        Cognitive decline and dementia in diabetes–systematic overview of prospective observational studies.
        Diabetologia. 2005; 48: 2460-2469
        • Xu W.L.
        • von Strauss E.
        • Qiu C.X.
        • Winblad B.
        • Fratiglioni L.
        Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.
        Diabetologia. 2009; 52: 1031-1039
        • Yaffe K.
        • Falvey C.
        • Hamilton N.
        • Schwartz A.V.
        • Simonsick E.M.
        • Satterfield S.
        • et al.
        Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.
        Arch Neurol. 2012; 69
        • Rawlings A.M.
        • Sharrett A.R.
        • Schneider A.L.
        • Coresh J.
        • Albert M.
        • Couper D.
        • et al.
        Diabetes in midlife and cognitive change over 20 years: a cohort study.
        Ann Intern Med. 2014; 161: 785-793
      1. Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M, Committee ADAPP, Committee: ADAPP. 13. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S195-S207.

        • Kodl C.T.
        • Seaquist E.R.
        Cognitive dysfunction and diabetes mellitus.
        Endocr Rev. 2008; 29: 494-511
        • Frier B.M.
        Hypoglycaemia and cognitive function in diabetes.
        Int J Clin Pract Suppl. 2001; 123: 30-37
        • Rama Chandran S.
        • Jacob P.
        • Choudhary P.
        A systematic review of the effect of prior hypoglycaemia on cognitive function in type 1 diabetes.
        Ther Adv Endocrinol Metab. 2020; 11
        • McCrimmon R.J.
        Consequences of recurrent hypoglycaemia on brain function in diabetes.
        Diabetologia. 2021; 64: 971-977
        • Cummings J.L.
        • Frank J.C.
        • Cherry D.
        • Kohatsu N.D.
        • Kemp B.
        • Hewett L.
        • et al.
        Guidelines for managing Alzheimer's disease: part I.
        Assessment. Am Fam Physician. 2002; 65: 2263-2272
        • Nasreddine Z.S.
        • Phillips N.A.
        • Bedirian V.
        • Charbonneau S.
        • Whitehead V.
        • Collin I.
        • et al.
        The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
        J Am Geriatr Soc. 2005; 53: 695-699
      2. Borson S.

        • Borson S.
        • Scanlan J.M.
        • Chen P.
        • Ganguli M.
        The Mini-Cog as a screen for dementia: validation in a population-based sample.
        J Am Geriatr Soc. 2003; 51: 1451-1454
        • Lessig M.C.
        • Scanlan J.M.
        • Nazemi H.
        • Borson S.
        Time that tells: critical clock-drawing errors for dementia screening.
        Int Psychogeriatr. 2008; 20: 459-470
        • Borson S.
        • Scanlan J.M.
        • Watanabe J.
        • Tu S.P.
        • Lessig M.
        Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample.
        J Am Geriatr Soc. 2005; 53: 871-874
        • Borson S.
        • Scanlan J.
        • Brush M.
        • Vitaliano P.
        • Dokmak A.
        The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly.
        Int J Geriatr Psychiatry. 2000; 15: 1021-1027
        • Bendel R.B.
        • Afifi A.A.
        Comparison of Stopping Rules in Forward ‘Stepwise’ Regression.
        Journal of the American Statistical Association. 1977; 72: 46-53
        • Sinclair A.J.
        • Gadsby R.
        • Hillson R.
        • Forbes A.
        • Bayer A.J.
        Use of the Mini-Cog as a screening tool for cognitive impairment in diabetes in primary care.
        Diabetes Res Clin Pract. 2013; 100: e23-e25
        • Kallumpuram S.
        • Sudhir Kumar C.T.
        • Khan B.
        • Gavins V.
        • Khan A.
        • Iliffe S.
        Targeted case finding for dementia in primary care: Surrey Downs dementia diagnosis project.
        BMJ Qual Improv Rep. 2015; 4
        • Yokomizo J.E.
        • Simon S.S.
        • Bottino C.M.
        Cognitive screening for dementia in primary care: a systematic review.
        Int Psychogeriatr. 2014; 26: 1783-1804
      3. Dove A, Marseglia A, Shang Y, Grande G, Vetrano DL, Laukka EJ, Fratiglioni L, Xu W. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression. Alzheimers Dement. 2022.doi: 10.1002/alz.12708. Epub ahead of print. PMID: 35708183.

        • Liu L.Y.
        • Lu Y.
        • Shen L.
        • Li C.B.
        • Yu J.T.
        • Yuan C.R.
        • et al.
        Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly.
        J Psychiatr Res. 2021; 145: 111-117
        • Planton M.
        • Raposo N.
        • Danet L.
        • Albucher J.F.
        • Péran P.
        • Pariente J.
        Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update.
        Rev Neurol (Paris). 2017; 173: 481-489
        • Pendlebury S.T.
        • Rothwell P.M.
        Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.
        Lancet Neurol. 2009; 8: 1006-1018
        • Pendlebury S.T.
        • Rothwell P.M.
        Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
        Lancet Neurol. 2019; 18: 248-258
        • Krannich J.H.
        • Tobias T.
        • Broscheit J.
        • Leyh R.
        • Müllges W.
        Diabetes severely affects attentional performance after coronary artery bypass grafting.
        J Cardiothorac Surg. 2012; 7: 115
        • Newman M.F.
        • Kirchner J.L.
        • Phillips-Bute B.
        • Gaver V.
        • Grocott H.
        • Jones R.H.
        • et al.
        Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.
        N Engl J Med. 2001; 344: 395-402
        • Evered L.A.
        • Silbert B.S.
        • Scott D.A.
        • Maruff P.
        • Ames D.
        Prevalence of Dementia 7.5 Years after Coronary Artery Bypass Graft Surgery.
        Anesthesiology. 2016; 125: 62-71
        • Lipnicki D.M.
        • Crawford J.D.
        • Dutta R.
        • Thalamuthu A.
        • Kochan N.A.
        • Andrews G.
        • et al.
        Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study.
        PLoS Med. 2017; 14: e1002261
        • Wisdom N.M.
        • Callahan J.L.
        • Hawkins K.A.
        The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.
        Neurobiol Aging. 2011; 32: 63-74
        • Jefferson A.L.
        • Himali J.J.
        • Au R.
        • Seshadri S.
        • Decarli C.
        • O'Donnell C.J.
        • et al.
        Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study).
        Am J Cardiol. 2011; 108: 1346-1351
        • Lanctôt K.L.
        • O'Regan J.
        • Schwartz Y.
        • Swardfager W.
        • Saleem M.
        • Oh P.I.
        • et al.
        Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
        Psychosomatics. 2014; 55: 61-68
        • Burkauskas J.
        • Noreikaite A.
        • Bunevicius A.
        • Brozaitiene J.
        • Neverauskas J.
        • Mickuviene N.
        • et al.
        Beta-1-Selective Beta-Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross-Sectional Study.
        J Neuropsychiatry Clin Neurosci. 2016; 28: 143-146
        • Burkauskas J.
        • Lang P.
        • Bunevičius A.
        • Neverauskas J.
        • Bučiūtė-Jankauskienė M.
        • Mickuvienė N.
        Cognitive function in patients with coronary artery disease: A literature review.
        J Int Med Res. 2018; 46: 4019-4031
        • Wang R.
        • Fratiglioni L.
        • Kalpouzos G.
        • Lövdén M.
        • Laukka E.J.
        • Bronge L.
        • et al.
        Mixed brain lesions mediate the association between cardiovascular risk burden and cognitive decline in old age: A population-based study.
        Alzheimers Dement. 2017; 13: 247-256
        • Speh A.
        • Wang R.
        • Winblad B.
        • Kramberger M.G.
        • Bäckman L.
        • Qiu C.
        • et al.
        The Relationship Between Cardiovascular Health and Rate of Cognitive Decline in Young-Old and Old-Old Adults: A Population-Based Study.
        J Alzheimers Dis. 2021; 84: 1523-1537
        • Saito T.
        • Yamada T.
        • Miyauchi Y.
        • Emoto N.
        • Okajima F.
        Analysis of Cognitive aging Estimated by the Japanese Version of the Montreal Cognitive Assessment in Patients Aged 75 years or Older with and Without Type 2 diabetes Mellitus.
        J Nippon Med Sch. 2021;
        • Lee Y.J.
        • Kang H.M.
        • Kim N.K.
        • Yang J.Y.
        • Noh J.H.
        • Ko K.S.
        • et al.
        Factors associated for mild cognitive impairment in older korean adults with type 2 diabetes mellitus.
        Diabetes Metab J. 2014; 38: 150-157
        • Zhang J.J.
        • Li L.
        • Liu D.
        • Hu F.F.
        • Cheng G.R.
        • Xu L.
        • et al.
        Urban-Rural Disparities in the Association Between Body Mass Index and Cognitive Impairment in Older Adults: A Cross-Sectional Study in Central China.
        J Alzheimers Dis. 2021; 83: 1741-1752
        • Dixon J.B.
        • Egger G.J.
        • Finkelstein E.A.
        • Kral J.G.
        • Lambert G.W.
        'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle.
        Int J Obes (Lond). 2015; 39: 82-84
        • Fitzpatrick A.L.
        • Kuller L.H.
        • Lopez O.L.
        • Diehr P.
        • O'Meara E.S.
        • Longstreth W.T.
        • et al.
        Midlife and late-life obesity and the risk of dementia: cardiovascular health study.
        Arch Neurol. 2009; 66: 336-342
        • Kuo H.K.
        • Jones R.N.
        • Milberg W.P.
        • Tennstedt S.
        • Talbot L.
        • Morris J.N.
        • et al.
        Cognitive function in normal-weight, overweight, and obese older adults: an analysis of the Advanced Cognitive Training for Independent and Vital Elderly cohort.
        J Am Geriatr Soc. 2006; 54: 97-103
        • Kronschnabl J.M.
        • Kneip T.
        • Weiss L.M.
        • Bergmann M.
        • Meyre D.
        Bodyweight change and cognitive performance in the older population.
        PLoS One. 2021; 16: e0249651
        • Sergi G.
        • De Rui M.
        • Stubbs B.
        • Veronese N.
        • Manzato E.
        Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons.
        Aging Clin Exp Res. 2017; 29: 591-597
        • Wells J.C.
        • Fewtrell M.S.
        Measuring body composition.
        Arch Dis Child. 2006; 91: 612-617
        • Rotonen S.
        • Auvinen J.
        • Bloigu A.
        • Härkönen P.
        • Jokelainen J.
        • Timonen M.
        • et al.
        Long-term dysglycemia as a risk factor for faster cognitive decline during aging: A 12-year follow-up study.
        Diabetes Res Clin Pract. 2021; 180: 109045
        • Launer L.J.
        • Miller M.E.
        • Williamson J.D.
        • Lazar R.M.
        • Gerstein H.C.
        • Murray A.M.
        • et al.
        Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.
        Lancet Neurol. 2011; 10: 969-977
        • Murray A.M.
        • Hsu F.C.
        • Williamson J.D.
        • Bryan R.N.
        • Gerstein H.C.
        • Sullivan M.D.
        • et al.
        ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.
        Diabetologia. 2017; 60: 69-80